Existing investors Lehman Brothers and Venrock Associates also participated in this financing round.
John Tighe, president and CEO of Peak Surgical, said: “The size, valuation and timing of this financing validates the progress we have made in advancing our pulsed plasma technology and developing our flagship product, the Peak Surgery System. This financing allows us to aggressively pursue the development plan and commercialization efforts for our Peak Surgery System, which we believe represents a quantum leap over surgical instruments in use today and will revolutionize the way surgery is performed.”